Targeting of dobutamine to ischemic myocardium without systemic effects by selective suction and pressure-regulated retroinfusion

Cardiovasc Res. 1997 Aug;35(2):233-40. doi: 10.1016/s0008-6363(97)00126-0.

Abstract

Objective: To study the effects of low-dose dobutamine and/or glyceryl trinitrate in addition to selective suction and pressure-regulated retroinfusion with arterial blood on regional myocardial function of the ischemic myocardium and systemic hemodynamics.

Methods: Using a pig model of repeated brief (90 s) occlusions of the left anterior descending artery, selective suction and pressure-regulated retroinfusion was carried out either with arterial blood alone (SSRalone) or with arterial blood and simultaneous application of low-dose dobutamine (0.1 microgram/kg/min (SSRDOB), glyceryl trinitrate (0.03 mg/kg/min) (SSRNIT) or the combination of both drugs (SSRDOB + NIT). Regional myocardial function of the ischemic and non-ischemic myocardium was determined by sonomicrometry (segment shortening).

Results: Segment shortening in the ischemic area after 90 s of ischemia was preserved at 57.5 +/- 9.2% with SSRalone but at 78.0 +/- 22.3% of baseline with SSRDOB (P < 0.05). The addition of glyceryl trinitrate did not improve regional myocardial function further. No effects of locally applied dobutamine were observed with regard to non-ischemic myocardium or heart rate. Cardiac output and mean arterial blood pressures tended to be further stabilized with SSRDOB.

Conclusions: Local application of low-dose dobutamine together with arterial blood by selective suction and pressure-regulated retroinfusion during brief myocardial ischemia resulted in improved regional myocardial function without undesired effects on non-ischemic myocardium or systemic hemodynamics.

MeSH terms

  • Animals
  • Blood Pressure / drug effects
  • Cardiac Output / drug effects
  • Cardiotonic Agents / administration & dosage*
  • Cardiotonic Agents / therapeutic use
  • Dobutamine / administration & dosage*
  • Dobutamine / therapeutic use
  • Drug Administration Schedule
  • Electrocardiography
  • Heart / physiopathology
  • Heart Rate / drug effects
  • Infusions, Intravenous
  • Myocardial Ischemia / drug therapy*
  • Myocardial Ischemia / physiopathology
  • Nitroglycerin / administration & dosage
  • Nitroglycerin / therapeutic use
  • Suction
  • Swine
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use
  • Ventricular Pressure / drug effects

Substances

  • Cardiotonic Agents
  • Vasodilator Agents
  • Dobutamine
  • Nitroglycerin